- Home
- SPAI vs ZTEK Comparison
SPAI vs ZTEK Comparison
Compare SPAI & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPAI | ZTEK |
|---|---|---|
| Founded | 2021 | 2008 |
| Country | United States | Canada |
| Employees | 15 | N/A |
| Industry | Industrial Specialties | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.4M | 68.8M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | SPAI | ZTEK |
|---|---|---|
| Price | $6.02 | $0.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 351.1K | 181.9K |
| Earning Date | 05-14-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1,060.58 | N/A |
| Revenue Next Year | $162.46 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.47 | $0.40 |
| 52 Week High | $9.16 | $1.55 |
Technical Indicators
Market Signals| Indicator | SPAI | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 69.96 | 43.91 |
| Support Level | $3.66 | $0.43 |
| Resistance Level | $7.39 | $0.75 |
| Average True Range (ATR) | 0.55 | 0.08 |
| MACD | 0.22 | -0.03 |
| Stochastic Oscillator | 76.48 | 3.38 |
Price Performance
Historical ComparisonAbout SPAI Safe Pro Group Inc.
Safe Pro Group Inc operates to acquire security and protection products. The company operated in three reportable business segments, which consisted of the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. The majority of revenue is from Safe-Pro USA.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.